XANAX XR SUMMARY
XANAX® XR CIV (alprazolam) extended-release tablets
XANAX XR Tablets contain alprazolam which is a triazolo analog of the 1,4 benzodiazepine class of central nervous system-active compounds.
XANAX XR Tablets are indicated for the treatment of panic disorder, with or without agoraphobia.
This claim is supported on the basis of two positive studies with XANAX XR conducted in patients whose diagnoses corresponded closely to the DSM-III-R/IV criteria for panic disorder (see CLINICAL STUDIES).
Panic disorder (DSM-IV) is characterized by recurrent unexpected panic attacks, ie, a discrete period of intense fear or discomfort in which four (or more) of the following symptoms develop abruptly and reach a peak within 10 minutes: (1) palpitations, pounding heart, or accelerated heart rate; (2) sweating; (3) trembling or shaking; (4) sensations of shortness of breath or smothering; (5) feeling of choking; (6) chest pain or discomfort; (7) nausea or abdominal distress; (8) feeling dizzy, unsteady, lightheaded, or faint; (9) derealization (feelings of unreality) or depersonalization (being detached from oneself); (10) fear of losing control; (11) fear of dying; (12) paresthesias (numbness or tingling sensations); (13) chills or hot flushes.
The longer-term efficacy of XANAX XR has not been systematically evaluated. Thus, the physician who elects to use this drug for periods longer than 8 weeks should periodically reassess the usefulness of the drug for the individual patient.
|
|
NEWS HIGHLIGHTS
Published Studies Related to Xanax XR (Alprazolam)
Comparison of alprazolam versus captopril in high blood pressure: a randomized controlled trial. [2011.08] CONCLUSION: A significant association exists between the level of BP and anxiety in hypertensive ED patients. Alprazolam is as effective as captopril in lowering BP in ED patients with an initial SBP > 160 mmHg.
Efficacy of alprazolam sublingual tablets in the treatment of the acute phase of panic disorders. [2011.03] CONCLUSIONS: Alprazolam has been demonstrated to have efficacy, safety and good tolerability in the treatment of the acute phase of panic disorder, the sublingual tablets showing some comparative advantages.
The efficacy and safety of alprazolam versus other benzodiazepines in the
treatment of panic disorder. [2011] We performed a meta-analysis of all single- or double-blind, randomized
controlled trials comparing alprazolam to another benzodiazepine in the treatment
of adult patients meeting the Diagnostic and Statistical Manual of Mental
Disorders, Third or Fourth Edition, criteria for panic disorder or agoraphobia
with panic attacks...
The effects of alprazolam on tinnitus: a cross-over randomized clinical trial. [2009.11] CONCLUSIONS: These results suggest that although alprazolam did not improve the THI score or sensation level of loudness significantly, it has a desirable effect on VAS. Further work is needed to determine the beneficial effects of alprazolam in distressed or depressed patients.
Does oral alprazolam affect ventilation? A randomised, double-blind, placebo-controlled trial. [2009.05] The respiratory effects of benzodiazepines have been controversial...
Clinical Trials Related to Xanax XR (Alprazolam)
A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks [Terminated]
The purpose of this study is to assess the long-term safety and tolerability of alprazolam
extended release (XR) in adolescents with panic disorder, with or without agoraphobia, or in
anxiety disorder with panic attacks. Efficacy, population pharmacokinetics of alprazolam XR
and the relationship between alprazolam XR plasma concentrations and efficacy outcomes will
also be evaluated.
Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation [Not yet recruiting]
This study tests the assumption that the bioavailability of alprazolam from a new sublingual
formulation is the same as that from an existing commercial immediate release tablet
formulation.
Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg [Completed]
The objective of this study was to investigate the bioequivalence of Mylan's alprazolam 1 mg
Extended-release tablets to Pharmacia & Upjohn's Xanax XR 1 mg tablets following a single,
oral 3 mg (3 x 1 mg) dose administered under fasting conditions.
Fed Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg [Completed]
The objective of this study was to investigate the bioequivalence of Mylan's alprazolam
Extended-release 3 mg tablets to Pharmacia & Upjohn's Xanax XR® 3 mg tablets following a
single, oral 3 mg (1 x 3 mg) dose administered under fed conditions.
Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg [Completed]
The objective of this study was to investigate the bioequivalence of Mylan's alprazolam 3 mg
Extended-release tablets to Pharmacia & Upjohn's Xanax XR® 3 mg tablets following a single,
oral 3 mg (1 x 3 mg) dose administered under fasting conditions.
Reports of Suspected Xanax XR (Alprazolam) Side Effects
Malaise (14),
Drug Ineffective (10),
Fatigue (8),
Feeling Abnormal (7),
Anxiety (6),
Somnolence (5),
Drug Intolerance (5),
Mental Disorder (5),
Depression (4),
Anaphylactic Reaction (3), more >>
|
PATIENT REVIEWS / RATINGS / COMMENTSBased on a total of 1 ratings/reviews, Xanax XR has an overall score of 8. The effectiveness score is 10 and the side effect score is 8. The scores are on ten point scale: 10 - best, 1 - worst.
| | Xanax XR review by 38 year old female patient | | | Rating |
| Overall rating: | |           |
| Effectiveness: | | Highly Effective |
| Side effects: | | Mild Side Effects | | | Treatment Info |
| Condition / reason: | | Anxiety Rapid Onset |
| Dosage & duration: | | .5 (dosage frequency: once daily xr) for the period of 20-30 for effectiveness |
| Other conditions: | | Sudden anxiety for 1st time |
| Other drugs taken: | | None | | | Reported Results |
| Benefits: | | Xanax XR .5 once daily for 2 days. This med works within 20-30 mins. A good solution for fast anxiety relief, as opposed to waiting 2 weeks for it to "settle" into your system. I think I might have done fine with .25 instead of the .50.
However, just reading about other people's anxiety accounts and Xanax has given me anxiety! |
| Side effects: | | A wee lethargic, but welcome feeling compared to... you know dying and hyperventilating. :) Definately tired. Maybe some minor bowel disturbances.
I am concerned about withdrawal so plan to take it on an as needed basis only! |
| Comments: | | Xanax XR .5 once daily for 2 days now. |
|
|
|
Page last updated: 2013-02-10
|